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ABSTRACT

The thesis entitled “Stereoselective Synthesis of Highly Substituted Tetrahydropyrans: Application in the Total Synthesis of Clavosolide A”, consists of two chapters:
CHAPTER I: Deals with the development of a methodology for the stereoselective synthesis of highly substituted tetrahydropyrans.
This chapter is divided into two parts:
Part A: Describes the synthesis of various highly substituted tetrahydropyrans including C20-C28 moiety of phorboxazoles.
Part B: Describes the synthesis of C5-C12 moiety of (–)-lasonolide A and common tetrahydropyran ring of (+)-sorangicin A and (–)-ratjadone. 
CHAPTER II: Deals with the total synthesis of clavosolide A.
This chapter is divided into three parts:
Part A: Describes the total synthesis of the reported structure of clavosolide A.
Part B: Describes the total synthesis of the marine natural product clavosolide A.
Part C: Describes the second generation total synthesis of clavosolide A.

CHAPTER I
Substituted tetrahydropyrans (THPs) are common structural features in an array of biologically active natural products, a large number of which incorporate a hydroxyl group (or glycoside linkage) at C-4. Total synthesis of these natural products depends largely on the efficient stereoselective construction of these essential cyclic components. We developed a new methodology for the stereoselective synthesis of highly substituted tetrahydropyrans following an acid or base catalyzed cycloetherification method. The idea emanated from the known susceptibility of linear molecules having SN2 active sites to undergo spontaneous ring closure, induced by heteroatoms at the δ-position to produce thermodynamically favourble six membered cyclic products. 

Part A
Synthesis of Various Highly Substituted Tetrahydropyrans Including C20-C28 Moiety of Phorboxazoles
Syntheses of highly substituted tetrahydro-2H-pyrans 1-5 were started from a common intermediate A, a propionate-derived polyketide unit. Tetrahydropyran 1 constitutes the C20-C28 moiety of phorboxazoles, the most cytotoxic natural products that have attracted wide attention of synthetic chemists. 
The salient feature of our strategy is the facile 6-exo SN2 type ring closure reaction mediated by different hydroxyl groups present in the acyclic precursor A. By carefully choosing the requisite nucleophilic oxygen and a suitable leaving group at -position, various tetrahydropyran frameworks were constructed as shown in Scheme 1. For the synthesis of the key building block A, a Ti(IV)-mediated ‘non-Evans’ Crimmins aldol reaction was employed to construct its C5 and C6 stereocenters. The chiral centers C3 and C4 were subsequently fixed by Sharpless epoxidation followed by a radical-mediated epoxide ring opening reaction, developed by us earlier for the synthesis of 2-methyl-1,3-diols, using cp2Ti(III)Cl. 

Scheme 1
Cyclization modes: a) C3-OH  C7-OX; b) C7-OH  C3-OX; c) C3-O  C7-OX; d) C5-O  C1-OX (X = Ms, Ts).

Our synthesis started with the mono benzyl protected propane-1,3-diol 6, which was subjected to Swern oxidation followed by Wittig olefination with stabilized ylide, Ph3PC(Me)CO2Et, to give exclusively the E-isomer of α,β-unsaturated ester 7 (Scheme 2). Reduction of the ester group using LiAlH4, followed by Swern oxidation furnished the trans α,β-unsaturated aldehyde 8. Asymmetric aldol addition of the titanium enolate derived from the N-propanoyl oxazolidinethione 9, to aldehyde 8 gave the ‘non-Evans’ syn aldol product 10 as the only isolable diastereomer.

Scheme 2
Reductive removal of the chiral auxiliary using NaBH4, followed by silyl protection of the primary alcohol, then E-allylic alcohol was subjected to Sharpless asymmetric epoxidation to furnish epoxy alcohol 11 (Scheme 3). Now the trisubstituted chiral epoxide 11 is ready to carry out the radical-mediated ring opening reaction using cp2TiCl. However, treatment of 11 with cp2TiCl gave the desired “2-methyl-1,3-diol” containing compound 13 along with an unexpected -hydrogen eliminated compound 12 as the major product. 

Scheme 3
Fortunately, diastereoselective reduction of the olefin moiety of 12 with H2 using 10% Pd-C as a catalyst in the presence of ammonium acetate transformed it into the desired product 13 (major isomer) with the requisite stereochemistry at the C4. The stereochemistry of 13 was ascertained by NMR study of its acetonide 14 (Scheme 4).

Scheme 4
Debenzylation of 13 was followed by selective protection of the hydroxyls at C1 and C3 as acetonide produced the intermediate 15. TBDPS deprotection of 15 followed by silylation using TBSOTf, further treatment with HF-py gave primary alcohol 16 (Scheme 5). The primary hydroxyl group of 16 was then oxidized using SO3-py and the resulting aldehyde 17 was treated with lithium trimethylsilylacetylide to give the propargylic alcohol 18 as a mixture of isomers. Finally, the C7-OH of 18 was mesylated and subsequently treated with a catalytic amount of ()-camphorsulphonic acid (CSA) to give the desired products 1 (C20-C28 moiety of phorboxazoles) and 2 (Scheme 6), which were separated easily by standard silica gel column chromatography and fully characterized.

Scheme 5
Although, our efforts to achieve diastereofacial selectivity during the addition of trimethylsilylacetylide to the aldehyde 17 were not very successful, subjection of the resulting mixture of alcohols 18 to a two-step process, oxidation followed by hydride reduction led to the desired diastereoselectivity. While reduction with L-selectride resulted in the best selectivity in favour of the anti isomer with an α-hydroxyl group at C7, reduction with Zn(BH4)2 favoured the formation of the syn isomer as the major product.


Scheme 6
For the synthesis of compounds 3 and 4, C1-C3 diol moiety of the intermediate triol derived from 13 was protected as PMP-acetal to furnish 19, the C5-OH was protected as benzyl ether followed by reduction with NaCNBH3 and TMS-Cl resulted the primary-protected substrate 20, exclusively (Scheme 7). Mesylation of the C3-OH followed by deprotection of the TBDPS group using TBAF led to a concomitant cycloetherification reaction in which the C7-alkoxide ion intramolecularly displaced the C3-OMs in SN2 fashion leading to the formation of the tetrahydropyran 3. 
Protection of the C3-OH of 20 as acetate and subsequent silyl deprotection gave the primary alcohol 21 (Scheme 8). The primary hydroxyl of 21 was then tosylated and finally base-catalyzed cyclization furnished the tetrahydropyran 4. 

Scheme 7
Reduction of 19 with NaCNBH3 and TMS-Cl gave the diol 22 (Scheme 9) as the minor product. Selective tosylation of the primary hydroxyl of 22 was followed by facile intramolecular cyclization initiated by the C5-O leading to the expected product 5.

Scheme 8
In conclusion, a versatile synthon A has been successfully and very efficiently exploited to construct a wide variety of structurally diverse chiral tetrahydropyran frameworks, including the one that bears the C20-C28 moiety of phorboxazoles. The protocol will be very useful in the synthesis of many such natural products that contain similar substituted tetrahydropyran moieties.


Part B
Synthesis of C5-C12 Moiety of (–)-Lasonolide A and Common Tetrahydropyran Ring of (+)-Sorangicin A and (–)-Ratjadone
In continuation of proving the practicality of our method for the construction of wide varieties of highly substituted THPs, we have paved a way to the core structures of biologically active and structurally complex architecture natural products like lasonolide A, sorangicin A and ratjadone. The basic strategy followed in our present work for the synthesis of C5-C12 moiety in (–)-lasonolide A, and common THP ring in C21-C28 moiety of (+)-sorangicin A and C15-C12 moiety in (–)-ratjadone are summarized in retrosynthetic Scheme 10.

Scheme 10
Tetrahydropyrans 23 and 24 were synthesized from a common intermediate 25, produced from 26, consisting of 2-methyl-1,3-diol moiety, which in turn can be prepared from either of the syn-epoxy alcohol 27 or anti-epoxy alcohol 28, via a  radical-mediated epoxide ring opening reaction (Scheme 10).

Synthesis of syn-epoxy alcohol 27:
Primary hydroxy group of the commercially available 3-methyl-2-butene-1-ol 29 was protected as benzyl ether, followed by the SeO2 oxidation furnished the α,β-unsaturated aldehyde 30. Treatment of the aldehyde 30 with Li-enolate of ethyl acetate, followed by the reduction of the ethyl ester group, using LiBH4, and selective silyl protection for the primary hydroxyl resulted the desired allylic alcohol 31 (Scheme 11).

Scheme 11
Enantiomerically pure allylic alcohol 33 was obtained from the racemic allylic alcohol 31 by Sharpless kinetic resolution (S.K.R) method, in which the unrequired isomer was converted to the corresponding anti-epoxy alcohol 32 (Scheme 12).

Scheme 12
Allylic alcohol 33 was treated with mCPBA to give the syn-epoxy alcohol 27 (Scheme 13). Now the syn-epoxy alcohol can be subjected to the radical-mediated epoxide ring opening at more substituted carbon using cp2TiCl to give the required 2-methyl-1,3-diol framework. 

Scheme 13

Synthesis of anti-epoxy alcohol 28:
	Commercially available 2-butyn-1-ol 34 was subjected to hydroalumination reaction with Red-Al, followed by quenching with I2 resulted the substituted cis-vinyl iodide 35. Allylic hydroxy group of 35 was protected as benzyl ether, using benzyl trichloroacetimidate to give desired compound 36 (Scheme 14).

Scheme 14
	Now vinyl iodide 36 was treated with nBuLi to generate the corresponding anion and addition of the aldehyde 37 to the reaction mixture produced 38, obviously, which is a racemic mixture. Racemic allylic alcohol 38 was subjected to Sharpless kinetic resolution to give the required anti-epoxy alcohol 28 and the unreacted (R)-allylic alcohol 39 was left over behind (Scheme 15).

Scheme 15
Now anti-epoxide 28 is also ready for the radical-mediated epoxide opening at more substituted carbon using cp2TiCl to give the 2-methyl-1,3-diol framework.

Synthesis of tetrahydropyrans 23 and 24:
The epoxy alcohols 27 or 28, on treatment with cp2TiCl, gave only one diastereomer 40 and no other isomer could be detected in the 1H NMR spectrum of the product 40 (Scheme 16).

Scheme 16
The diol compound 40 was treated with 2,2-DMP to give corresponding acetonide 26. The stereochemistry of 40 was ascertained by NMR study of its acetonide 26 (Scheme 17). 

	Selective silyl deprotection of 26, followed by Swern oxidation, then Wittig olefination with stabilized ylide, Ph3P=CHCO2Et, resulted the E-isomer of α,β-unsaturated ester 41, exclusively. Reduction of the ethyl ester group followed by Sharpless epoxidation furnished an epoxy alcohol 25 (Scheme 18).

Acid catalyzed deprotection of the acetonide 25 with concomitant cycloetherification via intramolecular 6-exo SN2 type ring closure using CSA produced the desired tertahydropyran 24 (Scheme 19). 

Scheme 19
Tetrahydropyran 23 was also achieved from the same common intermediate, i.e. epoxy alcohol 25, in four steps. Treatment of the epoxy alcohol with Red-Al, resulted in epoxide ring opening and primary hydroxy group was selectively silylated to produce desired compound 42 (Scheme 20). Finally, the secondary hydroxyl of 42 was mesylated and subsequent treatment with catalytic amount of ()-camphorsulphonic acid (CSA) produced the desired tetrahydropyran 23.

Scheme 20
	The concise method developed by us for the stereoselective synthesis of tetrahydropyran based molecular frameworks with different substituents attached to it, will find useful applications in the synthesis of many natural products.

CHAPTER II
The clavosolides A-D (1-4) are unusual macrodiolides, which have been isolated from extracts of the marine sponge Myriastra clavosa from Phillipines, in 2002. Crude extracts of Myriastra clavosa have displayed promising cytotoxic and antiproliferative effects in antitumor screens however thorough evaluation of the cytotoxic properties of the clavosolides has not been possible due to the limited natural abundance of these compounds.
They represent a new family of marine natural products incorporating several unusual structural features. These structures are quite unique because they are not related to any known sponge metabolites so far. The unique architecture of the clavosolides has attracted considerable interest within the synthetic community.
	
Figure 1


Part A

Total Synthesis of the Reported Structure of Clavosolide A

Clavosolide A is a C2-symmetric 16-membered dimeric macrolide with highly substituted tetrahydropyran units, disubstituted cyclopropyl rings and permethylated D-xylose moieties that had made its total synthesis a challenging task.
Retrosynthetic analysis for 1 is illustrated in Scheme 1. We envisaged that completion of synthesis of 1 relied on the coupling of diol 6 and the activated sugar moiety of 7 that was expected to be derived from D-xylose, via a Schmidt glycosidation. The C2-symmetric nature of diol 6 allowed us to disconnect it to a monomer unit 8. Monomer unit 8 would be prepared from substituted tetrahydropyran 9 by elaboration of the side-chain. Tetrahydropyran 9 can be constructed via a 6-exo SN2 type ring closure method from 2-methyl-1,3-diol moiety 10, which in turn can be prepared by a radical mediated epoxide ring opening route.


Scheme 1: Retrosynthetic analysis of the reported structure of clavosolide A

Our synthesis started with the racemic allylic alcohol 12 (prepared in five steps from 3-methyl-2-butene-1-ol following the reported procedure). Racemic allylic alcohol 12 was subjected to Sharpless kinetic resolution (S.K.R) to give the required anti-epoxy alcohol 11 and the unreacted R-allylic alcohol 13 was left over behind (Scheme 2).

Scheme 2
Now anti-epoxide 11 is ready for the radical-mediated epoxide ring opening at the more substituted carbon using cp2TiCl to give the 2-methyl-1,3-diol framework. The epoxy alcohol 11, on treatment with cp2TiCl, gave the desired compound 10 (Scheme 3) as the major diastereomer in 5:1 ratio, as determined by 1H NMR spectrum.

Scheme 3
The diol compound 10 was treated with 2,2-DMP and transformed to the corresponding acetonide 14 (Scheme 4). The stereochemistry of 10 was ascertained by NMR study of compound 14. 

Scheme 4
Selective silyl deprotection of compound 14 using TBAF gave primary alcohol 15. Primary alcohol 15 was subjected to Swern oxidation followed by Wittig olefination with stabilized ylide, Ph3P=CHCO2Et, to give exclusively the E-isomer of α,β-unsaturated ester 16. Reduction of the ethyl ester group was followed by Sharpless epoxidation to furnish an epoxy alcohol 17 (Scheme 5).

Scheme 5
Epoxy alcohol 17 was opened selectively using, Red-Al and subsequent silyl protection of primary alcohol to provide desired compound 18. Mesylation of the secondary alcohol 18 and acid-catalyzed deprotection of the acetonide with concomitant cycloetherification via a 6-exo SN2 type ring closure furnished the desired tetrahydropyran 9 (Scheme 6).

Scheme 6
Selective protection of the primary hydroxyl of 9 as an acetate and secondary hydroxyl as TBDPS gave the desired product 19. Deprotection of acetate under basic conditions provided primary alcohol 20 (Scheme 7). Primary alcohol 20 was subjected to Swern oxidation followed by nucleophilic addition of the lithium propynilide, generated from propyne and LDA, to give the desired propargylic alcohol 21 with S stereochemistry as the major isomer in 2:1 ratio.

Scheme 7
The stereochemistry of the major product propargylic alcohol 21 was confirmed by preparing the same product in the following manner. Primary alcohol 20 was subjected to the Swern oxidation followed by olefination with stabilized ylide, Ph3P=CHCO2Et, to give exclusively the E-isomer of α,β-unsaturated ester 23. Reduction of the ethyl ester to the corresponding allylic alcohol 24 was carried out using DIBAL-H. Sharpless epoxidation of allylic alcohol 24 with (+)-DIPT furnished an epoxy alcohol 25 (Scheme 8), which was converted to the corresponding epoxy chloride 26 using CCl4 and TPP. Epoxy chloride 26 was treated with LDA, followed by quenching with MeI to furnish the propargylic alcohol 21.

Scheme 8
The minor isomer 22 was subjected to Mitsunobu inversion followed by benzoate deprotection under basic conditions to furnish the required isomer 21 (Scheme 9).

Scheme 9
Reduction of propargylic alcohol 21 with Red-Al was followed by Charette modified Simmons-Smith cyclopropanation reaction to give, selectively, the syn product 27. Silylation of the hydroxyl group and subsequent benzyl ether deprotection provided the corresponding primary alcohol 28. Oxidation of the primary alcohol 28 with Dess-Martin periodianane (DMP) was followed by one-carbon Wittig olefination to furnish the desired compound 29 (Scheme 10). Hydroboration of 29 using (cHex)2BH followed by oxidative work-up gave primary alcohol, which  was oxidized to the corresponding acid 8 in two steps.

Scheme 10
Esterification of acid 8 with allyl bromide provided the desired allyl ester 30. Acid catalyzed TES deprotection of 30 furnished the hydroxy component 31 (Scheme 11), ready to be coupled with acid 8.

Scheme 11
The mixed anhydride obtained by reacting 8 with 2,4,6-trichlorobenzoyl chloride, following the Yamaguchi procedure, was treated with alcohol 31 in the presence of DMAP to furnish the fully protected linear dimer 32 (Scheme 12). TES deprotection of 32 using CSA, followed by Pd-catalyzed deallylation furnished hydroxy acid 33.

Scheme 12
The stage was now set to carry out the crucial macrolactonization reaction. Following the Yamaguchi procedure and a reverse-addition protocol, the mixed anhydride obtained by reacting 33 with 2,4,6-trichlorobenzoyl chloride was added using a syringe pump in ca 5 h to a solution of DMAP in toluene (final concentration 10-3 M) at 90 C, followed by desilylation using TBAF and catalytic amount of acetic acid to furnish the deprotected diolide aglycon 6 (Scheme 13).


Scheme 13
Glycosidation of 6 using 2,3,4-tri-O-methyl-D-xylopyranosyl trichloro acetimidate 7 furnished, as expected, a mixture of three products, which could be separated easily to give the desired β,β-product 1 (Scheme 14) along with the unwanted α,β-product 34 and α,α-product 35.

Scheme 14
	The 1H and 13C NMR spectra of synthetic 1 did not mach with those reported for natural clavosolide A and established that it is in fact a diastereomer of the natural product.

Part B
Total Synthesis of the Marine Natural Product Clavosolide A

Scheme 15: Retrosynthetic analysis of clavosolide A
Synthesis of the originally assigned structure of clavosolide A 1 by us and earlier by Willis and co-workers revealed that it was actually an isomer of the natural product. Willis and co-workers proposed a revised structure for clavosolide A 5 based on NMR and molecular modeling studies, which was first synthetically accomplished by Lee et al, later by us and others.
Retrosynthetic analysis for clavosolide A 5 is illustrated in Scheme 15, which is similar to the earlier described Scheme 1 and differs only at C9-stereochemistry. 

Scheme 16
Our synthesis started with the tetrahydropyranyl chiral alcohol 20 (described in Part A and Chapter II) which was synthesized applying a methodology developed for the synthesis of highly substituted tetrahydropyrans by a Ti(III)-mediated opening of trisubstituted epoxy alcohols.

Scheme 17
Primary alcohol 20 was subjected to Swern oxidation followed by nucleophilic addition of the lithium propynilide, generated from propyne and LDA, to give the propargylic alcohols 21 and 22 (Scheme 16) with the former as the major product in 2:1 ratio. The isomers could be separated easily by standard silica gel column chromatography. Earlier we carried out reduction of 21 with Red-Al to provide the E-allylic alcohol that was subjected to Charette modified Simmons-Smith cyclopropanation reaction giving selectively the syn-product. But the newly assigned structure of clavosolide A has an anti-relationship between the C9-O and the cyclopropane ring with (9S,10R,11R) and (9'S,10'R,11'R) configurations.This necessitated the use of the R propargylic alcohol 22 to give the requisite (R,R)-cyclopropane ring, since the cyclopropanation reaction is predominantly syn-selective. It was envisaged that inversion of the propargylic alcohol would re-establish its final S configuration. 
To have more quantities of the requisite propargylic alcohol 22, the major isomer 21 was subjected to Mitsunobu inversion followed by benzoate deprotection under basic conditions to provide 22 (Scheme 17).

Scheme 18
Reduction of propargylic alcohol 22 with Red-Al provided the E-allylic alcohol 38, which was subjected to a Charette modified Simmons-Smith cyclopropanation reaction to give, selectively, the syn product 39 (Scheme 18).

Scheme 19
However, Mitsunobu reaction failed to provide the inverted product. Therefore, an oxidation-reduction sequence was contemplated as there are many methods known for diastereoselective hydride reduction of cyclopropyl ketones. Oxidation of 39 with Dess-Martin periodinane (DMP) provided the keto intermediate 40, which was subjected to hydride reduction using Zn(BH4)2, to give the required S-isomer 41 (Scheme 19) as the major product in 5:1 ratio.

Scheme 20
Following the same procedure applied for compound 28, 29 and 8, carboxylic acid 37 was obtained from compound 41 (Scheme 20).

Scheme 21
Esterification of acid 37 with allyl bromide, followed by acid catalyzed TES deprotection furnished the hydroxy component 42 (Scheme 21), ready to be coupled with acid 37.

Scheme 22
Following the Yamaguchi procedure, the mixed anhydride obtained by reacting acid 37 with 2,4,6-trichlorobenzoyl chloride was treated with alcohol 42 in the presence of DMAP to furnish the fully protected linear dimer 43 (Scheme 22). Following the same procedure applied for compound 33 and 6, aglycon 36 was obtained from compound 43 (Scheme 23).

Scheme 23
Glycosidation of 36 using 2,3,4-tri-O-methyl-D-xylopyranosyl trichloro-acetimidate 7 furnished, as expected, a mixture of three products, which could be separated easily to give the desired β,β-product 5 (Scheme 24) along with the unwanted α,β-product 44 and α,α-product 45. 



Scheme 24
The 1H and 13C NMR spectra and optical rotation, [α]D -42.4 (c, 0.125, CHCl3), of our synthetic product 5 matched with those reported for the natural clavosolide A (literature [α]D -48.5 (c 1, CHCl3)).

Part C

Second Generation Total Synthesis of Clavosolide A
Although we and others (Lee, Willis and Smith) have successfully synthesized the clavosolide A 1, the unsatisfactory corner remained in all the syntheses is the forcible wastages of invaluable aglycon in the glycosidation step, i.e. the result of unrequired isomers along with final target. To rectify this problem of loosing the priceless material at the final step, we have gone for the glycosidation at the monomer stage and deglycosidation of unwanted α-isomer to recover the material as compound 9. Our approach is briefly outlined in Scheme 25.
Our synthesis started with the tetrahydropyran 9 (described in Part A and Chapter II) which was synthesized applying a methodology developed for the synthesis of highly substituted tetrahydropyrans by a Ti(III)-mediated opening of trisubstituted epoxy alcohols.


Scheme 25 
Primary alcohol 9 was protected, as a TBDPS to afford desired compound 49. Glycosidation of 49 using 2,3,4-tri-O-methyl-D-xylopyranosyl trichloroacetimidate 7 furnished, as expected, a mixture (1:1) of two products, which could be separated easily to give the desired β-product 47 (Scheme 26) along with the unwanted α-product 46.

Scheme 26
The unwanted α-product 46 was subjected to deglycosidation using HF-py, for recovering the material as tetrahydropyran 9 (Scheme 27) and the process was recycled to afford more quantities of the desired β-product 47.

Scheme 27

	The β-product 47 was subjected to desilylation to furnish primary alcohol 50, which was subjected to Swern oxidation followed by nucleophilic addition of the lithium propynilide, generated from propyne and LDA, to give the desired propargylic alcohols 51 and 52 (Scheme 28) with the former as the major product in 2:1 ratio and the isomers could be separated easily by standard silica gel column chromatography.

Scheme 28
The stereochemistry of the major product propargylic alcohol 51 was confirmed by preparing the same product in the following manner. Following the same procedure applied for compound 23, 24, 25, 26 and 21, propargylic alcohol 51 was obtained from primary alcohol 50  (Scheme 29).

Scheme 29

To have more quantities of the requisite propargylic alcohol 52, the major isomer 51 was subjected to Mitsunobu inversion followed by benzoate deprotection under basic conditions to provide 52  (Scheme 30).


Scheme 30

Following the same procedure applied for compound 38, 39, and 40, cyclopropyl ketone 53 was obtained from compound 47 (Scheme 31), which was subjected to LAH reduction to give the required S-isomer 54 as the major product in 5:1 ratio.

Scheme 31

Silylation of the hydroxyl group of 54, followed by benzyl ether deprotection provided primary alcohol 55. Oxidation of the primary alcohol 55 with Dess-Martin periodianane (DMP) and subsequent one-carbon Wittig olefination furnished the desired olefin 56. Hydroboration of 56 using (cHex)2BH was followed by oxidation with alkaline H2O2 to give primary alcohol, which  was oxidized to the corresponding carboxylic acid 57 in two steps. Carboxylic acid 57 was subjected to acid catalyzed desilylation to furnish the monomeric seco acid 48 (Scheme 32), a key intermediate for the cyclization.

Scheme 32
Monomer, seco acid 48 was subjected to critical cyclcodimerization to furnish the clavosolide A (5) (Scheme 33) under Yamaguchi conditions.

Scheme 33
The 1H and 13C NMR spectra and optical rotation, [α]D -42.4 (c, 0.125, CHCl3), of our synthetic product 5 matched with those reported for the natural clavosolide A (literature [α]D -48.5 (c 1, CHCl3)).
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